[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2019 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

June 2015 | 565 pages | ID: 2EEFEC914A9EN
Venture Planning Group

US$ 5,440.00 US$ 6,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $6,800. DataPack (test volumes, sales forecasts, supplier shares) $3,450. 2015 2019 UK Cancer Diagnostics Market is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion. Business Opportunities and Strategic RecommendationsSpecific new product development opportunities with potentially significant market appeal during the next five years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Cancer Diagnostic Tests Over 200 current and emerging assays including: ACTH, AFP, Beta 2 Microglobulin, CA 15 3/27. 29, CA 19 9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S 100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others. Market Segmentation Analysis Sales and market shares of major suppliers, by individual cancer diagnostic test. Five year test volume and sales forecasts for major cancer diagnostic tests by market segment, including: Hospitals Commercial/Private Laboratories Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
  • Cancer statistics, etiology and recent developments. Current and Emerging Products Review of over 200 current and emerging cancer diagnostic tests, including: Biochemical Markers Oncogenes Growth Factors Hormones Colony Stimulating Factors Lymphokines Immunohistochemical Stains, and others. Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling prices.

    Technology Review Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing. Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy. Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive AssessmentsStrategic assessments of major suppliers and start up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

    Contains 565 pages and 85 tables
  • 1. INTRODUCTION

    2. WORLDWIDE MARKET OVERVIEW

      1. Market Overview
      2. Worldwide Market Structure
      3. Worldwide Market Size and Growth

    3. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. Reagent Kits and Test Systems/Panels
    B. Instrumentation
    C. Computers, Software and Automation
    D. Auxiliary Products

    4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    5. ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies

    6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    7. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    A. Cancer Statistics and Etiology
      1. Breast Cancer
      2. Lung Cancer
      3. Colon and Rectum Cancer
      4. Prostate Cancer
      5. Stomach Cancer
      6. Leukemia
      7. Lymphoma
      8. Oral Cancer
      8. Skin Cancer
      10. Uterine Cancer
      11. Ovarian Cancer
      12. Bladder Cancer
    B. Major Current And Emerging Cancer Diagnostic Tests
      1. Introduction
      2. Tumor Marker Classification
      3. ACTH
      4. Alpha Fetoprotein (AFP)
      5. Beta-2 Microglobulin
      6. 15-3/27.29
      7. 19-8
      8. CA-125
      8. Calcitonin
      10. Carcinoembrionic Antigen (CEA)
      11. Estrogen and Progesterone Receptors
      12. Ferritin
      13. Gastrin
      14. Human Chorionic Gonadotropin (HCG)
      15. Insulin
      16. NSE
      17. Occult Blood
      18. PAP Smear/HPV
      19. Prostatic Acid Phosphatase (PAP)
      20. Prostate Specific Antigen (PSA)
      21. Squamous Cell Carcinoma Antigen (SCC)
      22. T and B Lymphocytes
      23. TdT
      24. Thyroglobulin
      25. Tissue Polypeptide Antigen (TPA)
      26. Biochemical Tumor Markers
      27. Oncogenes
        Abl/ablbcr
        AIB1
        BCL-2
        BRCA1
        CD44
        Cfos
        Cmyb
        Cmyc
        CYP-17
        ErbB
        HPC1
        Nmyc
        P40
        P51
        P53
        PIK3CA
        PTI-1
        Ras
        Reg
        Sis
        Src
      28. Polypeptide Growth Factors
        Basic Fibroblast Growth Factor
        Beta TGF
        Cachectin (TNT)
        Calmodulin
        ECFR
        Nerve Growth Factor (NGF)
        Epidermal Growth Factor (EGF)
        Ornithine Decarboxylase
        Transferrin
        Transforming Growth Factor Alpha
      29. Ectopic Hormones
      30. Colony Stimulating Factors
      31. Lymphokines
        Alpha Interferon
        B Cell Growth Factors
        B Cell Growth Factor (BCGF)
        Gamma Interferon
        Interleukin-1 (IL-1)
        Macrophage Activating Factor
      32. Immunohistochemical Stains
      33. Emerging Tumor Markers
        NAcetylglucosamine
        Actin
        Alpha Actin
        Antineuronal Antibodies
        7B2
        B72.3
        Bax
        BCD F9
        BLCA-4
        Blood Group Antigens A,B,H
        72-4/TAG-72
        CA-242
        CA-549
        CAM26
        CAR-3
        Cathepsin D
        Chromogranin A and B
        Cluster 1 Antigen
        Cluster-5/5A Antigen
        CTA
        CU18
        DR-70
        DUPAN-2
        Endometrial Bleeding Associated Factor
        Endostatin
        Epithelial Membrane Antigen
        Feulgen Hydrolysis
        Fibronectin
        FSH
        (1>3)fucosyltransferase
        Gastrin Releasing Peptide (GRP)
        GDCFP-15
        Glucagon
        Glycoamines
        H23
        Her-2
        Human Carcinoma Antigen
        HPA
        HSP27
        Intermediate Filaments
        Cytokeratins/CK18/Cyfra 21-1
        Desmin
        Gliofibrillary Acid Protein
        Neurofilaments
        Vimentin
        KA83
        Kinases
        KP16D3
        LAI
        Leukocyte Common Antigen
        Lewis Antigens
        Lysophosphatidic Acid (LPA)
        Ma 695/Ma
        MABDF3
        MAG
        ME1
        Minactivin
        MN/CA9
        MSA
        Mucin Cancer Antigen (MCA)
        Multiple Tumor Suppressor
        Myosin
        NEA-130
        NMP22
        OA-519
        Opiod Peptides
        Pglycoprotein
        Pancreatic Oncofetal Antigen (POA)
        Placental Lactogen
        PR92
        Proliferative Index, Ki-67
        Px
        RB Inactivation/Deletion
        Ret
        SCCL175
        Selectin
        Sialic Acid
        Sialyl SSEA-1/SLX
        SN10
        Somatostatin
        TA-80
        TABA
        Tachykinin
        TAG2
        TPS
        Troponin
        Tubulin
        VCAM
        VEGF
        Villen
    C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
    D. Current and Emerging Cancer Diagnostic Technologies
      1. Monoclonal and Polyclonal Antibodies
      2. Immunoassays
      3. Molecular Diagnostics
      4. Chromosome Analysis
        a. Chronic Myelogenous Leukemia (CML)
        b. Acute Myeloid Leukemia (AML)
        c. Acute Lymphoblastic Leukemia (ALL)
        d. Malignant Lymphomas Lymphoid Malignancies
        e. Chronic Lymphocytic Leukemia (CLL)
        f. Solid Cancers
        g. Chromosomal Translocation and Oncogenes
      5. Artificial Intelligence
      6. Flow Cytometry
      7. Two Dimensional Gel Electrophoresis (2DGE)
      8. Biosensors
      8. Competing/Complementing Technologies
    E. Personal Testing

    8. UK CANCER DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

    9. COMPETITIVE PROFILES

        Abbott
        AdnaGen/Alere
        Agilent Technologies
        Applied Gene Technologies
        Arca Biopharma
        Beckman Coulter/Danaher
        Becton Dickinson
        Biomedical Diagnostics
        bioMerieux
        Bio Rad
        CellSearch
        Cepheid
        Correlogic Systems/Vermillion
        Decode Genetics
        Diadexus
        Diagnocure
        Diasorin
        Eiken Chemical
        Elitech Group
        Epigenomics
        Enterix
        Enzo Biochem
        Exact Sciences
        Fujirebio
        Guided Therapeutics
        Hologic/Gen Probe
        Kreatech/Leica
        Kyowa Medex
        Mackay Life Sciences
        Myriad Genetics
        OncoLab
        Ortho Clinical Diagnostics
        Panacea Pharmaceuticals
        Polartechnics
        Polymedco
        PreMD
        Qiagen
        Quest Diagnostics
        Radient Pharmaceuticals
        Roche
        Scienion
        Sequenom
        Siemens Healthcare
        Takara Bio
        Targeted Diagnostics & Therapeutics
        Tosoh
        Thermo
        Veridex
        Wako Pure Chemicals
        Wallac/PE
        Zila

    10. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS

    LIST OF TABLES

    Tumor Marker Classification
    Major Companies Developing or Marketing ACTH Tests
    Major Companies Developing or Marketing AFP Tests
    Major Companies Developing or Marketing Beta-2 Microglobulin Tests
    Major Companies Developing or Marketing 15-3/27.29 Tests
    Major Companies Developing or Marketing 19-8 Tests
    Major Companies Developing or Marketing 125 Tests
    Major Companies Developing or Marketing Calcitonin Tests
    Major Companies Developing or Marketing CEA Tests
    Major Companies Developing or Marketing Estrogen Receptor Tests
    Major Companies Developing or Marketing Progesterone Receptor Tests
    Major Companies Developing or Marketing Ferritin Tests
    Major Companies Developing or Marketing Gastrin Tests
    Major Companies Developing or Marketing HCG Tests
    Major Companies Developing or Marketing Insulin Tests
    Major Companies Developing or Marketing NSE Tests
    Major Companies Developing or Marketing Occult Blood Tests
    Major Companies Developing or Marketing PAP Smear/HPV Tests
    Major Companies Developing or Marketing PAP Tests
    Major Companies Developing or Marketing PSA Tests
    Major Companies Developing or Marketing Lymphocyte Subclassification Tests
    Biochemical Markers Potential Applications In Cancer Diagnosis
    Oncogenes Potential Applications In Cancer Diagnosis
    Major Companies Developing or Marketing Oncogene Tests
    Growth Factors Potential Applications In Cancer Diagnosis
    Colony Stimulating Factors Potential Applications in Cancer Diagnosis
    Lymphokines Potential Applications In Cancer Diagnosis
    Immunohistochemical Stains Potential Applications in Cancer Diagnosis
    Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    U.K., Estimated Cancer Death Rates Per 100,000 Population
    U.K., Laboratories Performing Tumor Marker Tests by Market Segment
    U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
    U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
    U.K., All Market Segments Major Tumor Marker Test Volume Forecast
    U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    U.K., Total Tumor Marker Sales Forecast by Market Segment
    U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
    U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., 19-8 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Colon Specific Antigen Test Volume And Diagnostics Sales by Market Segment
    U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Total Tumor Marker Sales and Market Shares Forecast
    U.K., CEA Testing Market Diagnostics Sales by Major Supplier
    U.K., PSA Testing Market Diagnostics Sales by Major Supplier


    More Publications